Renal cell carcinoma: ten years of significant advances.
Rixe
Olivier
O
Rini
Brian
B
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D054316:Biomarkers, Pharmacological / Q000378:metabolism; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D055808:Drug Discovery; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D007211:Indoles / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008495:Medical Oncology / Q000639:trends; D009362:Neoplasm Metastasis; D011758:Pyrroles / Q000627:therapeutic use; D000077210:Sunitinib
D020533:Angiogenesis Inhibitors; D054316:Biomarkers, Pharmacological; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib